Clinical Trial Update: JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders

View source ↗

Summary

A clinical trial investigating JAK-STAT signaling in familial myeloproliferative disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Disorders

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myeloproliferative Disorders | Status: COMPLETED